# NAPSA

## Overview
NAPSA is a gene that encodes the protein napsin A, an aspartic peptidase involved in various physiological processes. Napsin A is primarily expressed in the lungs and kidneys, where it plays a critical role in the maturation of prosurfactant protein B, essential for lung function, and in lysosomal protein catabolism, contributing to cellular homeostasis (Lindskog2014The; Weidemann2021Napsin). As a member of the aspartic protease family, napsin A is characterized by its bilobal structure with a catalytic cleft containing aspartate residues crucial for its enzymatic activity (Nishishita2013Structural). Clinically, napsin A serves as a valuable biomarker in the diagnosis of lung adenocarcinoma and other cancers, aiding in distinguishing tumor origins (Weidemann2021Napsin). Its expression is regulated by thyroid transcription factor 1, underscoring its significance in cancer diagnostics (Weidemann2021Napsin).

## Structure
NAPSA, or napsin A, is an aspartic peptidase with a molecular structure characterized by a bilobal configuration, consisting of two domains that form a cleft where the active site is located. This cleft contains two catalytic aspartate residues essential for its enzymatic activity (Nishishita2013Structural). The primary structure of NAPSA includes a sequence of amino acids that form the polypeptide chain, with specific regions contributing to its functional properties. 

The secondary structure of NAPSA likely includes alpha helices and beta sheets, typical of aspartic peptidases, although specific details are not provided in the context. The tertiary structure involves the three-dimensional folding of the protein, which is crucial for its function. NAPSA's quaternary structure is not detailed in the provided context, suggesting it may function as a monomer.

NAPSA contains a unique RGD sequence near the C-terminal end, which is solvent-accessible and may play a role in its function (Nishishita2013Structural; Dunn2002Structure). Post-translational modifications such as glycosylation are common in aspartic peptidases, although specific modifications for NAPSA are not detailed in the context. NAPSA is expressed in lung and kidney tissues and is associated with membrane fractions when expressed in HEK293 cells (Dunn2002Structure).

## Function
Napsin A, encoded by the NAPSA gene, is an aspartic proteinase primarily expressed in the cytoplasm of type II pneumocytes, intra-alveolar macrophages, proximal and convoluted renal tubules, and pancreatic acini and ducts. In healthy human cells, Napsin A plays a crucial role in the maturation of prosurfactant protein B in type II pneumocytes, which is essential for maintaining proper lung function and surfactant processing, thereby facilitating normal respiration and gaseous exchange (Lindskog2014The; Weidemann2021Napsin). It is also involved in lysosomal protein catabolism in renal cells, contributing to cellular homeostasis (Weidemann2021Napsin).

Napsin A is regulated by thyroid transcription factor 1 (TTF1), which is significant in lung cancer diagnostics (Weidemann2021Napsin). Its expression is used as a diagnostic marker to determine the origin of tumors, particularly in distinguishing lung adenocarcinomas from other types of cancer (Lindskog2014The). The protein's activity in lysosomes and its involvement in protein maturation and catabolism highlight its importance in maintaining cellular and respiratory function (Weidemann2021Napsin).

## Clinical Significance
Napsin A, encoded by the NAPSA gene, is clinically significant due to its role as a biomarker in diagnosing certain cancers, particularly lung adenocarcinoma and renal cell carcinoma. In lung adenocarcinoma, Napsin A is highly expressed and is used diagnostically to confirm the presence of this cancer type (Weidemann2021Napsin). Its expression is regulated by thyroid transcription factor 1 (TTF1), which is crucial for its role in lung cancer diagnosis (Weidemann2021Napsin). In renal cell carcinoma, reduced expression of Napsin A is associated with adverse clinicopathological features, suggesting a potential role in tumor dedifferentiation (Weidemann2021Napsin). 

Napsin A is also expressed in ovarian clear cell adenocarcinoma and papillary renal cell carcinoma, where its expression correlates with certain clinicopathological features, such as low tumor grade and late recurrence in clear cell carcinomas, and low tumor stage and long tumor-specific survival in papillary renal cell carcinomas (Weidemann2021Napsin). However, multivariable analyses have shown no independent prognostic relevance (Weidemann2021Napsin). The limited expression of Napsin A in certain cancer types makes it a useful marker for assessing the site of origin of cancers, although there are potential diagnostic pitfalls, such as misdiagnosing lung metastases as primary adenocarcinomas based on Napsin A positivity (Weidemann2021Napsin).


## References


[1. (Nishishita2013Structural) Kazuhisa Nishishita, Eiko Sakai, Kuniaki Okamoto, and Takayuki Tsukuba. Structural and phylogenetic comparison of napsin genes: the duplication, loss of function and human-specific pseudogenization of napsin b. Gene, 517(2):147–157, April 2013. URL: http://dx.doi.org/10.1016/j.gene.2013.01.013, doi:10.1016/j.gene.2013.01.013. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2013.01.013)

[2. (Dunn2002Structure) Ben M. Dunn. Structure and mechanism of the pepsin-like family of aspartic peptidases. Chemical Reviews, 102(12):4431–4458, November 2002. URL: http://dx.doi.org/10.1021/cr010167q, doi:10.1021/cr010167q. This article has 289 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/cr010167q)

[3. (Lindskog2014The) Cecilia Lindskog, Linn Fagerberg, Björn Hallström, Karolina Edlund, Birte Hellwig, Jörg Rahnenführer, Caroline Kampf, Mathias Uhlén, Fredrik Pontén, and Patrick Micke. The lung‐specific proteome defined by integration of transcriptomics and antibody‐based profiling. The FASEB Journal, 28(12):5184–5196, August 2014. URL: http://dx.doi.org/10.1096/fj.14-254862, doi:10.1096/fj.14-254862. This article has 52 citations.](https://doi.org/10.1096/fj.14-254862)

[4. (Weidemann2021Napsin) Sören Weidemann, Jan Lukas Böhle, Hendrina Contreras, Andreas M. Luebke, Martina Kluth, Franziska Büscheck, Claudia Hube-Magg, Doris Höflmayer, Katharina Möller, Christoph Fraune, Christian Bernreuther, Michael Rink, Ronald Simon, Anne Menz, Andrea Hinsch, Patrick Lebok, Till Clauditz, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Eike Burandt, Rainer Krech, David Dum, Till Krech, Andreas Marx, and Sarah Minner. Napsin a expression in human tumors and normal tissues. Pathology and Oncology Research, April 2021. URL: http://dx.doi.org/10.3389/pore.2021.613099, doi:10.3389/pore.2021.613099. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/pore.2021.613099)